This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Jul;42(1):288-90.

doi: 10.1183/09031936.00191712.

Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence

Giovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, Antonio Spanevello, Giovanni Battista Migliori; International Group for the study of Linezolid

Collaborators

Collaborators

International Group for the study of Linezolid:
J W C Alffenaar, H A Anger, J A Caminero, P Castiglia, S De Lorenzo, G Ferrara, W J Koh, G F Schecter, T S Shim, R Singla, A Skrahina, Z F Udwadia, M Villar, E Zampogna, J P Zellweger, A Zumla

PMID: 23813314
DOI: 10.1183/09031936.00191712

Free article

Comment

Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence

Giovanni Sotgiu et al. Eur Respir J. 2013 Jul.

Free article

. 2013 Jul;42(1):288-90.

doi: 10.1183/09031936.00191712.

Authors

Giovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, Antonio Spanevello, Giovanni Battista Migliori; International Group for the study of Linezolid

Collaborators

International Group for the study of Linezolid:
J W C Alffenaar, H A Anger, J A Caminero, P Castiglia, S De Lorenzo, G Ferrara, W J Koh, G F Schecter, T S Shim, R Singla, A Skrahina, Z F Udwadia, M Villar, E Zampogna, J P Zellweger, A Zumla

PMID: 23813314
DOI: 10.1183/09031936.00191712

No abstract available

PubMed Disclaimer

Comment in

Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
Weiss T, Schönfeld N, Otto-Knapp R, Bös L, Bettermann G, Mauch H, Bauer TT, Rüssmann H. Weiss T, et al. Eur Respir J. 2015 Jan;45(1):285-7. doi: 10.1183/09031936.00084614. Eur Respir J. 2015. PMID: 25552739 No abstract available.
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
Sotgiu G, Centis R, D'Ambrosio L, Castiglia P, Migliori GB. Sotgiu G, et al. Eur Respir J. 2015 Jan;45(1):287-9. doi: 10.1183/09031936.00135014. Eur Respir J. 2015. PMID: 25552740 No abstract available.

Comment on

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
Sotgiu G, Centis R, D'Ambrosio L, Alffenaar JW, Anger HA, Caminero JA, Castiglia P, De Lorenzo S, Ferrara G, Koh WJ, Schecter GF, Shim TS, Singla R, Skrahina A, Spanevello A, Udwadia ZF, Villar M, Zampogna E, Zellweger JP, Zumla A, Migliori GB. Sotgiu G, et al. Eur Respir J. 2012 Dec;40(6):1430-42. doi: 10.1183/09031936.00022912. Epub 2012 Apr 10. Eur Respir J. 2012. PMID: 22496332
Linezolid for treatment of chronic extensively drug-resistant tuberculosis.
Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Jeon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee D, Kim CT, Dartois V, Park SK, Cho SN, Barry CE 3rd. Lee M, et al. N Engl J Med. 2012 Oct 18;367(16):1508-18. doi: 10.1056/NEJMoa1201964. N Engl J Med. 2012. PMID: 23075177 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Other Literature Sources
- scite Smart Citations